Dose–response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys

Background and purpose: The non‐selective β‐adrenoceptor antagonist, D,L‐sotalol (sotalol) is commonly employed as a positive control during preclinical cardiovascular safety pharmacology testing, mainly because of its ability to prolong QT interval duration. However, no information appears in the l...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of pharmacology Vol. 154; no. 7; pp. 1439 - 1445
Main Authors Lynch, J J, Wilson, A W, Hernandez, L E, Nelson, R A, Marsh, K C, Cox, B F, Mittelstadt, S W
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2008
Nature Publishing
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…